What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the […]

Continue Reading

Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The overall quality of indoor air at the office is taking center stage for many businesses. Cleaner air means a safer environment. And a safer environment leads to corporate trust and satisfaction.  Society spends approximately 90% of its time indoors, and nearly 50% of this time includes working for […]

Continue Reading

Statera BioPharma: The Ticker Formerly Known as CBLI

Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total […]

Continue Reading

Biotricity Reports Q1 Earnings at 290% for FY2022

Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two […]

Continue Reading

Generation Hemp’s Green Policy is Inspired by a Cause, Executives Move From Oil and Gas to Industrial Green

Green Policy, Generation Hemp, Melissa Pagen, Gary C Evans, Industrial Hemp Processor, Hemp Cleaning, Green Policy, ESG

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Generation Hemp, Inc. (OTCQB: GENH) is creating its own “Industrial Evolution,” leading an industry by example and contributing to a greener tomorrow. Ironically as it may seem, the company’s lead principals were once major players in the oil and gas industry — a notoriously sharp contrast to anything the world […]

Continue Reading